118 related articles for article (PubMed ID: 22507326)
1. Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer.
Papagerakis P; Pannone G; Shabana AH; Depondt J; Santoro A; Ghirtis K; Berdal A; Papagerakis S
Int J Immunopathol Pharmacol; 2012; 25(1):135-46. PubMed ID: 22507326
[TBL] [Abstract][Full Text] [Related]
2. Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma.
Su MC; Chen CT; Huang FI; Chen YL; Jeng YM; Lin CY
J Formos Med Assoc; 2014 Dec; 113(12):934-9. PubMed ID: 24021930
[TBL] [Abstract][Full Text] [Related]
3. Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression.
Bauman TM; Vezina CM; Ricke EA; Halberg RB; Huang W; Peterson RE; Ricke WA
Hum Pathol; 2016 May; 51():124-33. PubMed ID: 27067790
[TBL] [Abstract][Full Text] [Related]
4. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
5. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
[TBL] [Abstract][Full Text] [Related]
6. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary.
Fotopoulos G; Gousia A; Bareta E; Koumpis E; Chrisafi S; Bobos M; Malamou-Mitsi V; Fountzilas G; Pavlidis N; Pentheroudakis G
Eur J Clin Invest; 2015 Nov; 45(11):1145-52. PubMed ID: 26269154
[TBL] [Abstract][Full Text] [Related]
9. Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma.
Zhan Y; Feng J; Lu J; Xu L; Wang W; Fan S
J Clin Pathol; 2019 Jun; 72(6):425-430. PubMed ID: 30918012
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
12. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.
Shang D; Liu Y; Xu X; Han T; Tian Y
Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin and epithelial tumors: a study based on 374 oropharyngeal cancers.
Santoro A; Pannone G; Papagerakis S; McGuff HS; Cafarelli B; Lepore S; De Maria S; Rubini C; Mattoni M; Staibano S; Mezza E; De Rosa G; Aquino G; Losito S; Loreto C; Crimi S; Bufo P; Lo Muzio L
Biomed Res Int; 2014; 2014():948264. PubMed ID: 24511551
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl-prolyl isomerase Pin1-mediated abrogation of APC-β-catenin interaction in squamous cell carcinoma of cervix.
Jawanjal P; Salhan S; Dhawan I; Tripathi R; Rath G
Rom J Morphol Embryol; 2014; 55(1):83-90. PubMed ID: 24715170
[TBL] [Abstract][Full Text] [Related]
15. β-catenin (CTNNB1) mutation and LEF1 expression in sinonasal glomangiopericytoma (sinonasal-type hemangiopericytoma).
Suzuki Y; Ichihara S; Kawasaki T; Yanai H; Kitagawa S; Shimoyama Y; Nakamura S; Nakaguro M
Virchows Arch; 2018 Aug; 473(2):235-239. PubMed ID: 29736797
[TBL] [Abstract][Full Text] [Related]
16. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
18. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
19. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.
Bleckmann A; Siam L; Klemm F; Rietkötter E; Wegner C; Kramer F; Beissbarth T; Binder C; Stadelmann C; Pukrop T
Clin Exp Metastasis; 2013 Apr; 30(4):471-82. PubMed ID: 23224985
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of LEF1 and β-Catenin in Invasive Micropapillary Carcinoma of the Breast is Associated With Lymphovascular Invasion and Lymph Node Metastasis.
Dolezal D; Zhang X; Harigopal M
Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):557-565. PubMed ID: 35960138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
